3

A comparison of sampling methods to select real-world relapsed/refractory (R/R) diffuse large-cell B-cell lymphoma (DLBCL) patients with multiple eligible index dates

Thoughtful consideration should be given to sampling R/R DLBCL patients that should reflect the purpose of the study.